Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. - Abhik Kumar Ray; Parth Sarthi Sen Gupta; Saroj Kumar Panda; Satyaranjan Biswal; Uddipan Bhattacharya; Malay Kumar Rana (Comput. Biol. Medicine, 2022)